AngioDynamics, Inc. (FRA:UG2)

Market Cap	359.42M -24.9%
Revenue (ttm)	265.02M +7.3%
Net Income	-23.90M
EPS	-0.58
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	143
Open	8.20
Previous Close	8.30
Day's Range	8.20 - 8.75
52-Week Range	7.00 - 13.20
Beta	n/a
RSI	40.41
Earnings Date	Jan 6, 2026

About AngioDynamics

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company’s thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device tha...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1988
• Employees: 675
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: UG2

Financial Performance

In 2025, AngioDynamics's revenue was $292.50 million, a decrease of -3.76% compared to the previous year's $303.91 million. Losses were -$33.99 million, -81.56% less than in 2024.

Financial numbers in USD